Overview of the MINDACT trial results presented at EBCC-12

Bookmark and Share
Published: 16 Oct 2020
Views: 339
Prof Etienne Brain - EORTC Breast cancer group chair

Prof Etienne Brain discusses with ecancer the results of the MINDACT trial presented at EBCC-12.

He talks about the importance of this trial and why it was initiated in the first place and how the long term follow-up has proved successful in using certain drug combinations for chemotherapy against breast cancer.

He says age is also a factor that impacts the type and prognosis of chemotherapy used.